Investment thesis
IP Group is a London-listed investor that backs and grows science and technology businesses, with a second office in Melbourne. It concentrates on health tech, deep tech and clean tech, investing in the United Kingdom and Australia, where it recently launched a Climate Catalyst Fund. It aims for financial returns alongside social and environmental impact aligned with the UN Sustainable Development Goals.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| Microbiotica Cambridge, United Kingdom | Series C | Oct 2026 | €42.7M |
| Oxa Oxford, United Kingdom | Series D+ | Mar 2026 | €88.9M |